Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease

Name: Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease
Published: 2025
License: Public Domain

Akebia Therapeutics · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

anemia chronic-kidney-disease dialysis

anemia of chronic kidney disease, anemia, kidney disease, vadadustat, pediatric population, children, chronic kidney disease, erythropoiesis stimulating agent, dialysis, hypoxia-inducible factor (hif) prolyl hydroxylase inhibitor, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease

Related documents